The markets have been fairly volatile and uncertain over the past few months, but the Ocugen Inc (NASDAQ:OCGN) stock has continued to record steady gains during that period. However, investors must now be thinking whether Ocugen, which is now a coronavirus vaccine play, can continue to record gains.
Experts who are well versed in the concept of relative price strength have stated that the Ocugen stock has managed to perform particularly well if that metric is taken into consideration.
It has been suggested that as far as relative price strength is concerned, the Ocugen stock has been the best performer in the entire market over the course of the past six-month period and also the past one-year period. While this particular tool does provide important guidance with regards to the past performance of the Ocugen stock, it is still necessary for investors to do their own research before making any commitment.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.